129 related articles for article (PubMed ID: 9665206)
1. Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease?
How GF; Tan LT; Lim LC
Leukemia; 1998 Jul; 12(7):1166-7. PubMed ID: 9665206
[No Abstract] [Full Text] [Related]
2. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Gaiger A; Henn T; Hörth E; Geissler K; Mitterbauer G; Maier-Dobersberger T; Greinix H; Mannhalter C; Haas OA; Lechner K; Lion T
Blood; 1995 Sep; 86(6):2371-8. PubMed ID: 7662984
[TBL] [Abstract][Full Text] [Related]
3. bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient.
van der Plas DC; Soekarman D; van Gent AM; Grosveld G; Hagemeijer A
Leukemia; 1991 Jun; 5(6):457-61. PubMed ID: 2056770
[TBL] [Abstract][Full Text] [Related]
4. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R
Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria.
Branford S; Seymour JF; Grigg A; Arthur C; Rudzki Z; Lynch K; Hughes T
Clin Cancer Res; 2007 Dec; 13(23):7080-5. PubMed ID: 18056186
[TBL] [Abstract][Full Text] [Related]
6. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
7. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
Skórski T; Szczylik C; Malaguarnera L; Calabretta B
Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
[TBL] [Abstract][Full Text] [Related]
8. BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia.
Wilson G; Frost L; Goodeve A; Vandenberghe E; Peake I; Reilly J
Blood; 1997 Apr; 89(8):3064. PubMed ID: 9108430
[No Abstract] [Full Text] [Related]
9. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
[TBL] [Abstract][Full Text] [Related]
10. Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript.
Briz M; Vilches C; Cabrera R; Forés R; Fernández MN
Blood; 1997 Dec; 90(12):5024-5. PubMed ID: 9389724
[No Abstract] [Full Text] [Related]
11. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Langenhuijsen MM; Ossenkoppele GJ
Leukemia; 1997 Feb; 11(2):301-5. PubMed ID: 9009097
[TBL] [Abstract][Full Text] [Related]
12. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
13. Very late relapse with rapid BCR-ABL1 elevation after more than seven years of treatment-free remission with undetectable molecular residual disease in chronic myeloid leukaemia.
Katagiri S; Gotoh A; Ohyashiki K
Br J Haematol; 2020 Jan; 188(2):332-334. PubMed ID: 31702048
[No Abstract] [Full Text] [Related]
14. e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases.
Mondal BC; Majumdar S; Dasgupta UB; Chaudhuri U; Chakrabarti P; Bhattacharyya S
J Clin Pathol; 2006 Oct; 59(10):1102-3. PubMed ID: 17021137
[TBL] [Abstract][Full Text] [Related]
15. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.
Ni H; Nitta M; Komatsu H; Kojima S; Suzuki S; Harada S; Tsuboi K; Banno S; Wakita A; Yazaki M; Ren L; Kato T; Ueda R
Cancer Lett; 1998 Feb; 124(2):173-80. PubMed ID: 9500207
[TBL] [Abstract][Full Text] [Related]
16. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
MacKenzie E; Stewart E; Birnie GD
Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
[TBL] [Abstract][Full Text] [Related]
17. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia.
Verma RS; Chandra P
Leuk Res; 2000 Jul; 24(7):631-5. PubMed ID: 10867140
[No Abstract] [Full Text] [Related]
19. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases.
Martínez-López J; Ayala R; Albizua Q
Haematologica; 2002 Aug; 87(8):ELT35. PubMed ID: 12161380
[No Abstract] [Full Text] [Related]
20. No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia.
Opalka B; Wandl UB; Stutenkemper R; Kloke O; Seeber S; Niederle N
Blood; 1992 Oct; 80(7):1854-5. PubMed ID: 1391949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
